Biology articles
The Golden Goose Is Awarded
Salmonella Strain Spreads Alongside HIV
Fair Flu Viruses Closely Matched
Creative Emulsification
Inflammation for Regeneration
Editor's choice in microbiology
Debate Over Stem Cell Effectiveness
Editor's choice in molecular biology
Telomeres Affect Gene Expression
Re-sensitizing Resistant Bacteria
Vitamin C Slays TB Bacteria
Plant scientists, innovators
The First Plant Interactome
Plant RNAs Found in Mammals
Opinion: Beyond the Model
Sweet and Sour Science
Plant RNA Paper Questioned
Flower Barcodes
Microbial Perfume
How Plants Feel
New Databases Harvest a Rich Bounty of Information on Crop Plant Metabolism
Carnegie Institution for Science Receives Grand Challenges Explorations Grant
Genetically engineered trees could help restore devastated American chestnut
Evolution coup: study reveals how plants protect their genes
  Re-sensitizing Resistant Bacteria
A protein-lipid complex that naturally occurs in human breast milk can increase the sensitivity of methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant strains to multiple classes of antibiotics in animal models, according to a study published yesterday (May 1) in the PLOS ONE.

The findings suggest that the molecule—known as HAMLET (human alpha-lactalbumin made lethal to tumor cells)—could be useful as an antimicrobial adjuvant to boost otherwise ineffective antibiotics against MRSA and other “superbugs” that can cause lethal infectious outbreaks in hospitals.

HAMLET is one of the first antimicrobial adjuvant therapies to show efficacy in vivo, said Anders Hakansson, a microbiologist at the University of Buffalo and lead author of the study. “This molecule can help sensitize [resistant] bacteria to antibiotics we already have,” said Hakansson, “so we can again start using the treatment arsenal that was once available but that has been rendered ineffective.”

Additionally, if the compound does indeed prove effective in humans, HAMLET could be used to lower the doses of antibiotics needed to fight ordinary bacteria, which could slow the build up of resistance, he said.

But Karen Bush of Indiana University in Bloomington, who was not involved in the study, warned that “there are some problems with making this a viable therapeutic option. The main concern is that they are going to have to use high concentrations of HAMLET in order to affect all the MRSA strains out there,” which may not be cost effective and could bring problems with solubility and, potentially, toxicity.

But such problems may be avoided if HAMLET is used as a topical treatment for wound infections, she said. “I think this could be used topically, in treating wound infections, something where you spread it on the skin or on a dressing. Something like that could be effective.”

Hakansson began working with HAMLET—a lab-made combination of alpha-lactalbumin and one of two lipids, all of which are found in human breast milk—as a graduate student in Sweden. In 1995, he demonstrated that the protein complex killed tumor cells, and later showed that it does so by infiltrating the tumor cell’s mitochondria, depolarizing the inner membrane and inducing cell death.

In 2011, Hakansson’s group showed that HAMLET could also kill Streptococcus pneumoniae via a similar mechanism—a sodium-dependent influx of calcium ions that led to membrane depolarization. And last year they demonstrated that even at non-lethal concentrations, HAMLET sensitized the same bacterial pathogen to antibiotics.

To see if HAMLET would have the same potentiating effect on S. aureus, in which it did induce calcium influx but not apoptosis, Hakansson and his University of Buffalo colleagues Laura Marks and Emily Clementi used in vitro assays to show that the presence of HAMLET could make MRSA sensitive to methicillin, and render other resistant strains sensitive to vancomycin, erythromycin, and gentamycin. With HAMLET, these antibiotics not only inhibited the growth of the bacteria, but also killed them. The molecule had the same affect on antibiotic activity against S. aureus biofilms.

The team then tested the HAMLET/antibiotic combination on MRSA in the nasal passage of living mice, and found that while methicillin alone failed to reduce colonization, the combination produced a significant decrease.

Hakansson said that by blocking the cell’s hydrogen ion pump, HAMLET dissipates the proton gradient across the membrane. “This means the cell has a harder time making energy, so the cell’s efflux pumps—the usual mechanism for expelling antibiotics—would not work as effectively,” he said.

Methicillin works on the outside of the cell, however, so it is not clear how its efficacy is improved by HAMLET. Hakansson speculated that changes to the ion concentrations across the membrane could result in structural alterations to the cell wall that allow methicillin to bind more effectively. “It appears there are some changes in the cell wall that make it an easier target,” he said.

Finally, the researchers demonstrated that HAMLET inhibits the evolution of methicillin resistance even as the bacteria are repeatedly exposed to increased concentrations of the antibiotic.

“They certainly show there is a slower development of resistance, but they’re still seeing resistance,” Bush noted. “There is no way you’re going to shut down resistance completely.”

Nevertheless, Hakansson has confidence in the approach, and has cofounded a company to test HAMLET on different bacteria and infection models. “I’m hoping this [work] will trigger more thought in this direction—rather than trying to find new antibiotics, looking at adjuvants would not be a bad idea.”
buy viagra online
Plants Put Limit on Ice Ages
Carnegie donates landmark clones to biology
Plants on Steroids: Key Missing Link Discovered
Gene Function Discovery: Guilt by Association
Cracking the Plant-Cell Membrane Code
Private Support Helps Public Plant Research
Scientists Watch Cell-Shape Process for First Time
How plants choose their mates
Mastermind Steroid Found in Plants
Unlocking the secrets of a plant’s light sensitivity
Nailing down a crucial plant signaling system
What makes a plant a plant?
New component of a plant steroid-activated pathway discovered
Big Boost to Plant Research
The Heart of the Plant
New tool offers unprecedented access for root studies
Steroids control gas exchange in plants
Plant toughness: Key to cracking biofuels?
Amoeba may offer key clue to photosynthetic evolution
The future of plant science – a technology perspective
Plant research funding crucial for the future
Wolf B. Frommer Receives Bogorad Award for Excellence in Plant Biology
Lighting up the plant hormone “command system”
Plant organ development breakthrough
Breakthrough: How salt stops plant growth
New Cancer Diagnostic Technique Debuts
Plant Science Could Ease Global Food and Fuel Demands
Have you had your cereal today?
Researchers close in on engineering recognizable, drug-free Cannabis plant
UC Riverside Researchers Develop Genetic Map for Cowpea
New research shows how mobile DNA survives—and thrives—in plants, animals
Cucumber Genome Published
Structural study at EMBL reveals how plants respond to water shortages
“Safety Valve” Protects Photosynthesis from Too Much Light
Weeds Could Help To Feed The World
Antagonistic Genes Control Rice Growth
Making New Enzymes to Engineer Plants for Biofuel Production
Green Plant Transport Mystery Solved
Gene Discovery To Increase Biomass Needed For Green Fuel
Are genes our destiny?
New African cassava resists devastating viruses
Species richness and genetic diversity do not go hand in hand in alpine plants
Scientists discover how cancer may take hold
Green algae—the nexus of plant/animal ancestry
New Twist on Life’s Power Source
Controlling a sea of information
Plant Steroids Offer New Paradigm for How Hormones Work
Future of biology rests in harnessing data avalanche
Carnegie’s Arthur Grossman Receives Gilbert Morgan Smith Medal
Plant Scientists Participate in DOE Energy Frontier Research Center
Advance in understanding cellulose synthesis
Midget Plant Gets Makeover